Walleye Trading’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,457
| Closed | -$911K | – | 4107 |
|
|
2026
Q1 | $719K | Buy |
2,457
+182
| +8% | +$59.8K | ﹤0.01% | 2350 |
|
|
2025
Q4 | $798K | Buy |
2,275
+824
| +57% | +$278K | ﹤0.01% | 2522 |
|
|
2025
Q3 | $469K | Sell |
1,451
-1,284
| -47% | -$399K | ﹤0.01% | 2783 |
|
|
2025
Q2 | $1.06M | Sell |
2,735
-7,764
| -74% | -$3.12M | ﹤0.01% | 2159 |
|
|
2025
Q1 | $4.57M | Buy |
+10,499
| New | +$4.21M | 0.01% | 1153 |
|
|
2024
Q3 | – | Sell |
-2,938
| Closed | -$1.57M | – | 4213 |
|
|
2024
Q2 | $1.59M | Buy |
2,938
+831
| +39% | +$439K | ﹤0.01% | 1748 |
|
|
2024
Q1 | $1.09M | Sell |
2,107
-21,598
| -91% | -$10.7M | ﹤0.01% | 2170 |
|
|
2023
Q4 | $11.2M | Buy |
23,705
+5,565
| +31% | +$2.57M | 0.02% | 723 |
|
|
2023
Q3 | $7.9M | Buy |
18,140
+17,646
| +3,572% | +$8M | 0.02% | 809 |
|
|
2023
Q2 | $219K | Sell |
494
-2,342
| -83% | -$1.08M | ﹤0.01% | 3370 |
|
|
2023
Q1 | $1.3M | Sell |
2,836
-14,054
| -83% | -$6.69M | ﹤0.01% | 2009 |
|
|
2022
Q4 | $8.66M | Buy |
16,890
+6,708
| +66% | +$3.41M | 0.02% | 750 |
|
|
2022
Q3 | $4.63M | Buy |
10,182
+2,842
| +39% | +$1.36M | 0.01% | 1088 |
|
|
2022
Q2 | $3.54M | Buy |
7,340
+6,239
| +567% | +$3.09M | 0.01% | 1245 |
|
|
2022
Q1 | $541K | Buy |
+1,101
| New | +$503K | ﹤0.01% | 2827 |
|
|
2021
Q3 | – | Sell |
-393
| Closed | -$149K | – | 5323 |
|
|
2021
Q2 | $150K | Buy |
+393
| New | +$150K | ﹤0.01% | 4153 |
|
|
2020
Q1 | – | Sell |
-1,034
| Closed | -$282K | – | 4107 |
|
|
2019
Q4 | $312K | Buy |
+1,034
| New | +$285K | ﹤0.01% | 2787 |
|
|
2019
Q1 | – | Sell |
-978
| Closed | -$283K | – | 4340 |
|
|
2018
Q4 | $257K | Buy |
+978
| New | +$269K | ﹤0.01% | 3130 |
|
|
2018
Q3 | – | Sell |
-2,955
| Closed | -$767K | – | 5336 |
|
|
2018
Q2 | $703K | Sell |
2,955
-22,757
| -89% | -$5.27M | ﹤0.01% | 2486 |
|
|
2018
Q1 | $5.65M | Buy |
25,712
+13,119
| +104% | +$3.08M | 0.03% | 482 |
|
|
2017
Q4 | $2.83K | Buy |
+12,593
| New | +$2.68M | 0.01% | 1050 |
|
|
2017
Q3 | – | Sell |
-3,799
| Closed | -$723K | – | 4206 |
|
|
2017
Q2 | $715 | Buy |
3,799
+1,394
| +58% | +$250K | ﹤0.01% | 2055 |
|
|
2017
Q1 | $398 | Buy |
2,405
+2,369
| +6,581% | +$377K | ﹤0.01% | 2433 |
|
|
2016
Q4 | $5K | Buy |
+36
| New | +$4.82K | ﹤0.01% | 4453 |
|
|
2015
Q3 | – | Sell |
-4,282
| Closed | -$644K | – | 5086 |
|
|
2015
Q2 | $703K | Buy |
4,282
+2,271
| +113% | +$363K | 0.01% | 1390 |
|
|
2015
Q1 | $311K | Buy |
+2,011
| New | +$286K | ﹤0.01% | 1861 |
|
|
2014
Q3 | – | Sell |
-5,225
| Closed | -$599K | – | 4149 |
|
|
2014
Q2 | $562 | Buy |
+5,225
| New | +$538K | 0.01% | 1180 |
|
|
2014
Q1 | – | Sell |
-12,145
| Closed | -$1.1M | – | 3612 |
|
|
2013
Q4 | $1.12M | Buy |
12,145
+3,597
| +42% | +$320K | 0.01% | 1027 |
|
|
2013
Q3 | $715K | Buy |
8,548
+3,680
| +76% | +$315K | 0.01% | 1028 |
|
|
2013
Q2 | $398K | Buy |
+4,868
| New | +$364K | ﹤0.01% | 1360 |
|
Other funds holding ELV
AACR
Walleye Trading's ELV Position: Q2 2026 in Review
Walleye Trading sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 2,457 shares — an estimated $911K sold.
Walleye Trading first reported a position in ELV in Q2 2013 and held it in 30 quarters. The position peaked at $11.2M in Q4 2023. 917 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Walleye Trading reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Walleye Trading sold 2,457 Elevance Health shares in Q2 2026, an estimated $911K.
- Walleye Trading first reported a position in Elevance Health in Q2 2013 and held it in 30 quarters.
- Walleye Trading's Elevance Health position peaked at $11.2M in Q4 2023.
- 917 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.